Epidemiology of HIV-related neuropathy: a systematic literature review. Read more about Epidemiology of HIV-related neuropathy: a systematic literature review.
Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy. Read more about Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy.
Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study. Read more about Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study.
Continued evolution in gp41 after interruption of enfuvirtide in subjects with advanced HIV type 1 disease. Read more about Continued evolution in gp41 after interruption of enfuvirtide in subjects with advanced HIV type 1 disease.
Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). Read more about Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).
A rapid and sensitive real-time PCR assay for the K65R drug resistance mutation in SIV reverse transcriptase. Read more about A rapid and sensitive real-time PCR assay for the K65R drug resistance mutation in SIV reverse transcriptase.
The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response. Read more about The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response.
Potential herpesvirus interaction during HIV type 1 primary infection. Read more about Potential herpesvirus interaction during HIV type 1 primary infection.
Anemia and HIV in the antiretroviral era: potential significance of testosterone. Read more about Anemia and HIV in the antiretroviral era: potential significance of testosterone.
Two percent of HIV-positive U.S. blood donors are infected with non-subtype B strains. Read more about Two percent of HIV-positive U.S. blood donors are infected with non-subtype B strains.
